Aditx Therapeutics
Dolly is a Professor Emerita of Pathology at Stanford University School of Medicine. He is board-certified in Histocompatibility & Immunogenetics with 45 years of experience. Medical Director of Stanford Histocompatibility, Immunogenetics, & Disease Profiling Lab until 2019. Inventor of 4 issued patents in Immunotherapy & Immune Profiling Technology.
Aditx Therapeutics
Aditx Therapeutics, Inc. (Aditxt™) is a biotech innovation company with a mission of prolonging life and enhancing its quality by improving the health of the immune system.